Glycan Biomarkers for Rheumatoid Arthritis and Its Remission Status in Han Chinese Patients

OMICS A Journal of Integrative Biology

Volumn 20, Issue 6, 2016, Pages 343-351

  Sebastian, Andrea ^a   Alzain, Mohamed Ali ^a   Asweto, Collins Otieno ^a   Song, Haicheng ^b   Cui, Liufu ^b   Yu, Xinwei ^a,c   Ge, Siqi ^a,c   Dong, Hao ^a   Rao, Ping ^a   Wang, Hao ^a   Fang, Honghong ^a   Gao, Qing ^a   Zhang, Jie ^a   He, Dian ^a   Guo, Xiuhua ^a   Song, Manshu ^a   Wang, Youxin ^a   Wang, Wei ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCAN; IMMUNOGLOBULIN G; N ACETYLGLUCOSAMINE; POLYSACCHARIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DAS28; FEMALE; GLYCOBIOLOGY; GLYCOSYLATION; HAN CHINESE; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SYNAPOMORPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AREA UNDER THE CURVE; CASE CONTROL STUDY; METABOLISM; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; ROC CURVE;

EID: 84975452694     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2016.0050     Document Type: Article

References (48)

1. Abés R, and Teillau JL. (2010). Impact of glycosylation on effector functions of therapeutic IgG. Pharmaceuticals 3, 146-157.
2. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al. (2010). 2010 Rheumatoid arthritis classification criteria. Arthritis Rheum 62, 2569-2581.
3. Aletaha D, Ward MM, Machold KP, Nell VPK, Stamm T, and Smolen JS. (2005). Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states. Arthritis Rheum 52, 2625-2636.
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. (1988). The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-324.
5. Chabchoub G, Uz E, Maalej A, Mustafa CA, Rebai A, Mnif M, et al. (2009). Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther 11, 106-113.
6. Choy E. (2012). Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51, 3-11.
7. Collins ES, Galligan MC, Saldova R, Adamczyk B, Abrahams JL, Campbell MP, et al. (2013). Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment. Rheumatology 52, 1572-1582.
8. Cutolo M. (2009). Androgens in rheumatoid arthritis: When are they effectors? Arthritis Res Ther 11, 126-128.
9. Ebell MH. (2016). Evidence-based practise for the health professions: Receiver operating characteristic curves. Course. Retrieved from The University of Georgia College of Public Health website http://ebp.uga.edu/courses/Chapter%204%20- %20Diagnosis%20I/8%20-%20ROC%20curves.html. Accessed February 24, 2016.
10. Ercan A, Cui J, Hazen MM, Batliwalla F, Royle L, Rudd PM, et al. (2012). Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther 14, 43-50.
11. Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, et al. (2012). High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 44, 1336-1342.
12. Forslind K, Hafström I, Ahlmén M, and Svensson B. (2007). Sex: A major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66, 46-52.
13. Goeldner I, Skare T, de Messias Reason IT, Nisihara RM, Silva MB, and da Rosa Utiyama SR. (2010). Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 49, 1590-1593.
14. Gornik I, Maravić G, Dumić J, Flögel M, and Lauc G. (1999). Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Chem Biochem 32, 605-608.
15. Herman S, Zurgil N, Langevitz P, Ehrenfeld M, and Deutsch M. (2009). The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations. Immunol Invest 33, 351-362.
16. Huffman JE, Pućić-Baković M, Klarić L, Hennig R, Selman MHJ, Vučković F, et al. (2014). Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13, 1598-1610.
17. Kaneko Y, Nimmerjahn F, and Ravetch JV. (2006). Antiinflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673.
18. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. (2012). Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FccRIIB and dectin-1. Nat Med 18, 1401-1406.
19. Kiltz U, and van der Heijde D. (2009). Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin Exp Rheumatol 27, S108-S111.
20. Lauc G. (2012). The future of glycoscience. Biochim Biophys Acta 1820, 1305.
21. Lauc G, Essafi A, Huffman JE, Hayward C, Knežević A, Kattla JJ, et al. (2010). Genomics meets glycomics-The first GWAS study of human N-glycome identifies HFN1a as a master regulator of plasma protein fucosylation. PLoS Genet 6, e1001256.
22. Lauc G, Huffman JE, Pučić M, Zgaga L, Adamczyk B, Mužinić A, et al. (2013). Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet 9, e1003225.
23. Lauc G, Krištić J, and Zoldoš V. (2014). Glycans-The third revolution in evolution. Front Genet 5, 145.
24. Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW, et al. (2012). Epidemiology of eight common rheumatic diseases in China: A large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51, 721-729.
25. Lin G, and Li J. (2010). Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int 30, 837-840.
26. Lu JP, Knežević A, Wang YX, Rudan I, Campbell H, Zou ZK, et al. (2011). Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations. J Proteome Res 10, 4959-4969.
27. Majithia V, and Geraci SA. (2007). Rheumatoid arthritis: Diagnosis and management. Am J Med 120, 936-939.
28. Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmačić I, et al. (2013). Glycosylation of immunoglobulin G: Role of genetic and epigenetic influences. PLoS One 8, e82558.
29. Mota-Miranda ACA, Barreto FK, Baptista E, Monteiro-Cunha J, Farre-Valve L, Galvao-Castro B, et al. (2014). Molecular study of HBZ and gp21 human T cell lymphotropic virus type 1 proteins isolated from different clinical profile infected individuals. Retrovirology 11, 84.
30. Novokmet M, Lukić E, Vučković F, Durić Z, Keser T, Rajšl K, et al. (2014). Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep 4, 4347.
31. Oliver JE, and Silman AJ. (2009). Why are women predisposed to autoimmune rheumatic diseases?Arthritis Res Ther 11, 252-260.
32. Petzke MM, Suri PK, Bungiro R, Goldberg M, Taylor SH, Ranji S, et al. (2000). Schistosoma mansoni gene GP22 encodes the tegumental antigen Sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine. Parasite Immunol 22, 381-395.
33. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. (2007). TRAF1-C5 as a risk locus for rheumatoid arthritis-A genomewide study. N Engl J Med 357, 1199-1209.
34. Pučić M, Knežević A, Vidič J, Adamczyk B, Novokmet M, Polašek O, et al. (2011). High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10, M111.010090.
35. Ruegg CL, Monell CR, and Strand M. (1989). Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J Virol 63, 3250-3256.
36. Saber TP, Ng CT, Renard G, Lynch BM, Pontifex E, Walsh CAE, et al. (2010). Remission in psoriatic arthritis: Is it possible and how can it be predicted? Arthritis Res Ther 12, R94.
37. Scott DL, Wolfe F, and Huizinga T. (2010). Rheumatoid arthritis. Lancet 376, 1094-1108.
38. Scott IC, Tan R, Stahl D, Steer S, Lewis CM, and Cope AP. (2013). The protective effect of alcohol on developing rheumatoid arthritis: A systemic review and meta-analysis. Rheumatology (Oxford) 52, 856-867.
39. Shade KTC, and Anthony RM. (2013). Antibody glycosylation and inflammation. Antibodies 2, 392-414.
40. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al. (2009). Women, men, and rheumatoid arthritis: Analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11, R7.
41. Sundaram R, Lynch MP, Rawale SV, Sun Y, Kazanji M, and Kaumaya PTP. (2004). De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies. J Biol Chem 279, 24141-24151.
42. Takahashi M, Kuroki Y, Ohtsubo K, and Taniguchi N. (2009). Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: Their functions and target proteins. Carbohydr Res 344, 1387-1390.
43. Tape TG. (2016). Interpreting diagnostic tests: Using the receiver operating characteristic (ROC) curve to analyze a classification model. Notes. Retrieved from University of Nebraska. Medical Center. Department of Internal Medicine website http://gim.unmc.edu/dxtests/Default.htm. Accessed February 24, 2016.
44. Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić- Baković M, Zoldoš V, et al. (2014). The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 11, 588-600.
45. Toussirot E. (2010). Predictive factors for disability as evaluated by the health assessment questionnaire in rheumatoid arthritis: A literature review. Inflamm Allergy Drug Targets 9, 51-59.
46. Vučković F, Krištić J, Gudelj I, Artacho MT, Keser T, Pezer M, et al. (2015). Systemic lupus erythematosus associates with the decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 67, 2978-2989.
47. Zhang XL. (2006). Roles of glycans and glycopeptides in immune system and immune-related diseases. Curr Med Chem 13, 1141-1147.
48. Zochling J, and Braun J. (2009). Mortality in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 27, S127-S130.